My Blog
Business

Palo Alto, Eli Lilly and Eaton are up big. Here are some entry prices


Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. 

George Frey | Bloomberg | Getty Images

Palo Alto Networks, Eli Lilly, and Eaton rallied hard over the past 12 months — up 127%, 117% and 66%, respectively. It’s wonderful news for existing shareholders. But it’s not great for investors waiting for pullbacks to start positions — unless you want to buy at or near record highs, which is something we never recommend.

Related posts

‘Reckless’ to discuss defeating Russia, says former consultant to Soviet Union

newsconquest

U.S. approves Boeing inspection, rework plan to resume 787 deliveries

newsconquest

Pfizer (PFE) Q4 earnings report 2023

newsconquest

Leave a Comment